Journal article
Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in canadian adults with chronic immune thrombocytopenic purpura
Abstract
OBJECTIVE: The aim of this work was to estimate the cost-effectiveness of intravenous immunoglobulin (IVIg) compared with oral prednisone as a treatment for Canadian adults with persistent chronic immune thrombocytopenic purpura (ITP).
METHODS: The lifetime costs and effectiveness of IVIg and prednisone were estimated from the perspective of a publicly funded health care system in Canada, using a Markov model that was developed based on a …
Authors
Xie F; Blackhouse G; Assasi N; Campbell K; Levin M; Bowen J; Tarride J-E; Pi D; Goeree R
Journal
Clinical Therapeutics, Vol. 31, No. 5, pp. 1082–1091
Publisher
Elsevier
Publication Date
May 2009
DOI
10.1016/j.clinthera.2009.05.006
ISSN
0149-2918